Article: Advances In Wound Healing and Surgical Scar Reduction To Be Discussed in Hot Topics Seminar, April 21.

ORLANDO, Fla., April 21 /PRNewswire/ -- Two new products, that hold promise in surgical scar prevention and wound closure will be discussed, debated and evaluated by some of the world's leading plastic surgeons at this year's Hot Topics seminar at the Annual Meeting of the American Society for Aesthetic Plastic Surgery (ASAPS), April 21-25 in Orlando, FL.

Juvista, currently in phase II clinical trials in the UK, is an injectable that is placed in wounds at the time of closure in an effort to decrease scarring. The pharmaceutical product consists of TGF BETA-3 (Transforming Growth Factor Beta 3), a naturally occurring protein that is present in high levels in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!